Does risk for ovarian malignancy algorithm excel human epididymis protein 4 and ca125 in predicting epithelial ovarian cancer: A meta-analysis
出版年份 2012 全文链接
标题
Does risk for ovarian malignancy algorithm excel human epididymis protein 4 and ca125 in predicting epithelial ovarian cancer: A meta-analysis
作者
关键词
-
出版物
BMC CANCER
Volume 12, Issue 1, Pages -
出版商
Springer Nature
发表日期
2012-06-28
DOI
10.1186/1471-2407-12-258
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Systematic Reviews of Diagnostic Test Accuracy
- (2013) Mariska M.G. Leeflang ANNALS OF INTERNAL MEDICINE
- QUADAS-2: A Revised Tool for the Quality Assessment of Diagnostic Accuracy Studies
- (2013) Penny F. Whiting ANNALS OF INTERNAL MEDICINE
- Golgi protein 73 versus alpha-fetoprotein as a biomarker for hepatocellular carcinoma: a diagnostic meta- analysis
- (2012) Ying Zhou et al. BMC CANCER
- Improved blood tests for cancer screening: general or specific?
- (2011) Ian A Cree BMC CANCER
- Myofibrillogenesis regulator 1 (MR-1) is a novel biomarker and potential therapeutic target for human ovarian cancer
- (2011) Renquan Lu et al. BMC CANCER
- HE4 and CA125 as a diagnostic test in ovarian cancer: prospective validation of the Risk of Ovarian Malignancy Algorithm
- (2011) T Van Gorp et al. BRITISH JOURNAL OF CANCER
- Serum Human Epididymis Protein 4 and Risk for Ovarian Malignancy Algorithm as New Diagnostic and Prognostic Tools for Epithelial Ovarian Cancer Management
- (2011) E. Bandiera et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Diagnostic performances of HE4 and CA125 for the detection of ovarian cancer from patients with various gynecologic and non-gynecologic diseases
- (2011) Yongjung Park et al. CLINICAL BIOCHEMISTRY
- The ROMA (Risk of Ovarian Malignancy Algorithm) for estimating the risk of epithelial ovarian cancer in women presenting with pelvic mass: is it really useful?
- (2011) Martina Montagnana et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- No benefit from combining HE4 and CA125 as ovarian tumor markers in a clinical setting
- (2011) Francis Jacob et al. GYNECOLOGIC ONCOLOGY
- Human Epididymis Protein 4 (HE4) as a Serum Tumor Biomarker in Patients With Ovarian Carcinoma
- (2011) Xiaohong Chang et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Evaluation of the Diagnostic Accuracy of the Risk of Ovarian Malignancy Algorithm in Women With a Pelvic Mass
- (2011) Richard G. Moore et al. OBSTETRICS AND GYNECOLOGY
- Human epididymis protein 4 reference limits and natural variation in a Nordic reference population
- (2011) Nils Bolstad et al. TUMOR BIOLOGY
- E2F5 status significantly improves malignancy diagnosis of epithelial ovarian cancer
- (2010) Narasimhan Kothandaraman et al. BMC CANCER
- Development of a Multimarker Assay for Early Detection of Ovarian Cancer
- (2010) Zoya Yurkovetsky et al. JOURNAL OF CLINICAL ONCOLOGY
- When are summary ROC curves appropriate for diagnostic meta-analyses?
- (2009) F. M. Chappell et al. STATISTICS IN MEDICINE
- The Preclinical Natural History of Serous Ovarian Cancer: Defining the Target for Early Detection
- (2009) Patrick O. Brown et al. PLOS MEDICINE
- A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass
- (2008) Richard G. Moore et al. GYNECOLOGIC ONCOLOGY
- The use of multiple novel tumor biomarkers for the detection of ovarian carcinoma in patients with a pelvic mass
- (2007) Richard G. Moore et al. GYNECOLOGIC ONCOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started